Company page

Myriad Genetics, Inc.

Myriad Genetics, Inc. (Ticker: MYGN) is a publicly traded company based in America, with a market capitalization of approximately $428.8 million. The company specializes in genetic testing and precision medicine, focusing on improving patient care through innovative solutions. Myriad's offerings aim to provide valuable insights for healthcare providers and patients alike.